# Oregon Clinical and Translational Research Institute

> **NIH NIH UL1** · OREGON HEALTH & SCIENCE UNIVERSITY · 2021 · $6,307,995

## Abstract

The Oregon Clinical and Translational Research Institute (OCTRI) has been accelerating research at Oregon
Health & Science University since 2006. Its many highly functional programs assist investigators and trainees
by providing diverse services. Here, we propose that OCTRI will transition to retain our strengths, but also
become a key hub in the national network, by focusing on five crosscutting aims. These align closely with the
goals of the Funding Opportunity Announcement, and the goals outlined by NCATS for the CTSA program in
an ideal state. OCTRI's overall aims are to:
Overall Aim 1: Catalyze Clinical and Translational Research.
Overall Aim 2: Enhance Partnerships with Communities.
Overall Aim 3: Foster and Support Scientific Collaboration.
Overall Aim 4: Expand the Translational Workforce for the 21st Century.
Overall Aim 5: Cultivate Innovation in Research.
We have organized a highly functional leadership structure to enable us to meet these goals, and will seek the
guidance of several advisory groups. We will catalyze research by developing and supporting new informatics
approaches that both integrate the clinical care enterprise with the research enterprise and facilitate the
recruitment of patients into clinical trials, locally and across the CTSA network. We will engage diverse
stakeholders in the translational research process, by partnering with OHSU investigators, community
coalitions, and business enterprises. We will foster team science through local awards to trainees and to
emerging investigators. We will partner with regional institutions to foster community-engaged research, to
enhance the diversity of trainees, and to provide opportunities in biomedical research not available at other
institutions. We will train clinical and translational scientists and research staff for the next generation, by
focusing on the skills and attitudes necessary for research in the future. At all steps, we will measure outcomes
and, when necessary, “turn the curve.”

## Key facts

- **NIH application ID:** 10198068
- **Project number:** 5UL1TR002369-05
- **Recipient organization:** OREGON HEALTH & SCIENCE UNIVERSITY
- **Principal Investigator:** David Hoadley Ellison
- **Activity code:** UL1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $6,307,995
- **Award type:** 5
- **Project period:** 2017-09-02 → 2022-08-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10198068

## Citation

> US National Institutes of Health, RePORTER application 10198068, Oregon Clinical and Translational Research Institute (5UL1TR002369-05). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10198068. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*